Apotakamo, the web pharmacy from Sweden, has been raised 2.5 million euros in funding. The corporate will use the cash for geographical growth, advertising actions and the platform’s logistics resolution. The startup needs to develop into the main pharmacy in Southeast Europe.
Apotekamo is a startup, initially based in Serbia, providing over-the-counter and prescribed drugs in addition to digital companies for third-party suppliers comparable to order processing and cost options. The corporate is especially energetic in South-Jap Europe and a part of Swedish enterprise builder EPTI.
Now, the web pharmacy has raised 2.5 million euros with a pre-money valuation of 14.6 million euros. Mom firm EPTI shared the information on their web site.
Apotekamo will use the funds for additional geographical growth in Southeast Europe. The startup has simply expanded to Bosnia and Herzegovina at the beginning of 2022 after buying an area pharmacy. Moreover, the cash might be put in direction of elevated advertising operations and the startup’s logistics companies.
‘Delighted given the present market local weather’
As a part of the funding, FC Bayern Munich’s Sporting Director and former soccer participant Hasan Salihamidžić grew to become the third largest shareholder and might be a part of the corporate’s advertising actions.
CEO Srdjan Milic of Apotekamo: “We’re delighted with the belief from present and new buyers, particularly given the present market local weather and the geopolitical state of affairs.”
740% elevated order consumption
The startup elevated its order consumption by 740 p.c throughout the first half of 2022 in comparison with the identical interval final 12 months, the CEO says. In accordance with Milic, it’s Apokamo’s intention to develop into the main on-line pharmacy in Southeast Europe.